Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

Michael J. Fisher(Children's Hospital of Philadelphia), D. Wade Clapp(Indiana University School of Medicine)
Nature Medicine
January 1, 2021
Cited by 95


Related Papers